CanadaCGM.com https://validator.w3.org/feed/docs/rss2.html Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada Hypoglycemia in Adults Continuous glucose monitoring in diabetes improves outcomes and enhances patient self-management How Continuous Glucose Monitoring Can Motivate Self-Management: Can Motivation Follow Behaviour? 2025 ADA Standards of Care Key Considerations for CGM Integration in Quality Improvement Glycemic Management Across the Lifespan for People With Type 1 Diabetes: A Clinical Practice Guideline Continuous glucose monitoring in noninsulin-treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials Canada CGM Manitoba & Saskatchewan Announce Expanded Coverage for Diabetes Technology Employers play important role in preventing and managing diabetes P.E.I. government makes important investment in support of Islanders living with diabetes Diabetes organization pleased with Manitoba government’s commitment to help youth with the disease Enhanced Supports For Saskatchewan Residents With Diabetes Initiating cgm is associated with improvements in glycemic control Study Shows Disparities in CGM Prescribing for Vulnerable Patient Populations Social Experiences of Living with Diabetes in Canada rtCGM Public Coverage in Canada Infographic Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada Survey By Employee Benefit News Shows Digital Health Tools From Third-Party Vendors Can Increase Utilization and Enhance Wellness Programming Government of Manitoba Announces Diabetes Action Plan Focused on Prevention, Management, and Access to Medication and Technology Régie de l’assurance maladie du Québec Eases Requirements for Dexcom CGM Reimbursement Evidence-Based Rationale for Expanding Access to CGM in Individuals with Type 2 Diabetes Treated with Nonintensive Therapies Large, Single-Center Study Shows that Increased Utilization of Technology Significantly Improved Glycemic Outcomes in Type 1 Diabetes Next-Generation Dexcom G7 CGM System Approved by Health Canada A review of the symposium: “Eureka Moments: How Real-time Continuous Blood Glucose Monitoring (rtCGM) Has Changed Our Practice” At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible Using Continuous Glucose Monitoring to Aid in Virtual Care and Improve Diabetes Management Payer and Health System Experts Share Insights on the Role of CGM in Population Health Management AMCP Market Insights Health Plan Best Practice: Implementing continuous glucose monitoring to improve patient outcomes in diabetes Nova Scotia Now Providing Coverage for G6 and G7 CGM Large, Real-World Retrospective Study Shows Reduced Health Care Resource Utilization and Improved Glycemic Outcomes with CGM in T2D Regardless of Treatment Type ADA 2023 Highlights: The Clinical and Economic Value of CGM 2024 Vancouver Benefits Summit Study Finds Poor Attainment of Glycemic Targets Across Canada Affected by Income and Location All NIHB Plan Members Ages 2 Years and Older Managing Their Type 1 or Type 2 Diabetes with Insulin are Eligible for Dexcom G6 Coverage Manitoba has Expanded Coverage for Advanced Glucose Monitors and Insulin Pumps to Manitobans over the Age of 18 Disparities in Hemoglobin A1C in the First Year After Diagnosis Among Youths with Type 1 Diabetes Offered Continuous Glucose Monitoring Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom CanadaCGM.com Expert Interview with Michael C. Riddell, PhD CanadaCGM.com Expert Interview with Dr. Alexander Abitbol, MDCM, FRCPC Cost-effectiveness of Real-Time Continuous Glucose Monitoring Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021 LOIS-P Study Examines Insulin Use and Glycemic Control in Pregnancy with CGM LOIS-P Looks at Hypoglycemia Incidence with Sensor-Augmented Pump in Pregnancy New Diabetes Technology & Therapeutics Supplement Highlights the Latest CGM Evidence and Insights Continuing Education Programs: Improving Health Outcomes with CGM CGM Associated with Reduced Cost and Health Care Resource Utilization in Intensive Insulin-Treated T2D CGM Improves Glycemic Control and Reduces CVD Risk in Non-Insulin-Treated T2D rtCGM Public Coverage in Canada*